glp-1 receptor agonist diarrhea management Full article: Managing the gastrointestinal side effects of agonists in obesity: recommendations for clinical practice GLP-1 for Crohn's Disease: Current
Description
This collaborative review process ensures that every article meets the highest standards of medical accuracy, reliability, and relevance
25.2 months for the PIONEER 6 and SUSTAIN-6 trials, respectively) [35,36], the HR of the PIONEER 6 study may have been statistically significant if the follow-up duration had been longer
Hansen HH, Barkholt P, Fabricius K, et al
PubMed, Pham, Hung, et al
